Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-12-21 5:22 pm Unchanged | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 3,021,529 8.8% | 0 (Unchanged) | View |
| 2022-04-01 4:38 pm Sale | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 3,021,529 9.05% | -626,826 (-17.18%) | View |
| 2022-02-22 11:22 am Unchanged | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 3,648,355 10.93% | 0 (Unchanged) | View |
| 2019-11-08 2:04 pm Sale | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 3,648,355 11.29% | -9,825 (-0.27%) | View |
| 2019-10-07 4:48 pm Purchase | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 3,658,180 11.32% | 730,503 (+24.95%) | View |
| 2019-08-02 6:02 pm Unchanged | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 2,927,677 19.12% | 0 (Unchanged) | View |
| 2018-08-24 5:22 pm Unchanged | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 2,927,677 19.87% | 0 (Unchanged) | View |
| 2018-06-29 5:23 pm Purchase | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 2,927,677 19.87% | 2,927,677 (New Position) | View |